Edgewise Therapeutics (EWTX) total debt

Total debt · fiscal 2025
$3.99M

Edgewise Therapeutics (EWTX) carried total debt of $3.99M at the end of fiscal 2025 (December 31, 2025). That is 15.8% lower than the $4.74M of fiscal 2024. Figures as of 18 Nov 2026, 07:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$3.99M
Change on fiscal 2024
−15.8%
Highest on record
$5.41Mfiscal 2023
Lowest on record
$3.99Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Edgewise Therapeutics total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $5.41M in fiscal 2023 and the lowest $3.99M in fiscal 2025.

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Edgewise Therapeutics total debt, year by year

Edgewise Therapeutics (EWTX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$3.99M 15.8% down0.0×
2024$4.74M 12.5% down0.0×
2023$5.41M 22.8% up0.0×
2022$4.41M—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Edgewise Therapeutics and comparable companies
CompanyTotal debtFiscal year
Concentra Group Holdings Parent CON$2.10B2025
Merit Medical Systems MMSI$821.57M2025
Edgewise Therapeutics EWTX$3.99M2025
LivaNova LIVN$433.77M2025
Ionis Pharmaceuticals IONS$2.06B2025
Dianthus Therapeutics DNTH$1.39M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EWTX

Edgewise Therapeutics, figure by figure

Edgewise Therapeutics (EWTX) overview: price, valuation and scorecardAll health care companies by market value

Edgewise Therapeutics total debt: questions and answers

How much debt does Edgewise Therapeutics have?

Edgewise Therapeutics (EWTX) carried total debt of $3.99M at the end of fiscal 2025 (December 31, 2025). That is 15.8% lower than the $4.74M of fiscal 2024.

What are the highest and lowest total debt figures on record for Edgewise Therapeutics?

Across the 4 fiscal years on record (2022–2025), the highest was $5.41M in fiscal 2023 and the lowest $3.99M in fiscal 2025.

How does Edgewise Therapeutics's debt compare with its equity?

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

How is Edgewise Therapeutics's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Edgewise Therapeutics (EWTX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/EWTX/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.